H
ARNA

Hexavest’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Hexavest’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,488
Closed -$482K – 460
2020
Q1 		$482K Hold
11,488
– – 0.01% 231
2019
Q4 		$522K Buy
11,488
+7,429
+183% +$351K 0.01% 242
2019
Q3 		$186K Buy
+4,059
New +$228K ﹤0.01% 307

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hexavest's ARNA Position: Q2 2020 in Review

Hexavest sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 11,488 shares — an estimated $482K sold.

Hexavest first reported a position in ARNA in Q3 2019 and held it in 3 quarters. The position peaked at $522K in Q4 2019. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

  • Hexavest reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Hexavest sold 11,488 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $482K.
  • Hexavest first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 3 quarters.
  • Hexavest's Arena Pharmaceuticals Inc position peaked at $522K in Q4 2019.
  • 247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Hexavest's 13F filing for Q2 2020, filed 10 Jul 2020.